Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benzopyrazine derivatives: A novel class of growth factor receptor bound protein 7 antagonists

Published:2011-01 Issue:1 Volume:19 Page:693-701
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Ambaye Nigus D.,Gunzburg Menachem J.,Lim Reece C.C.,Price John T.,Wilce Matthew C.J.,Wilce Jacqueline A.

Funder

Australian Research Council Project Grant

National Health and Medical Research Council of Australia

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference64 articles.

1. Grb7 in intracellular signaling and its role in cell regulation

2. Grb7 Upregulation Is a Molecular Adaptation to HER2 Signaling Inhibition Due to Removal of Akt-Mediated Gene Repression

3. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.

4. Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease

5. Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grb7 knockout mice develop normally but litters born to knockout females fail to thrive;Developmental Dynamics;2023-12-23

2. GRB7 plays a promoting role in the progression of gastric cancer;BMC Cancer;2023-12-21

3. Grb7 knockout mice develop normally but litters born to knockout females fail to thrive;2023-07-01

4. One-pot synthesis of cyclic-aminotropiminium carboxylate derivatives with DNA binding and anticancer properties;Communications Chemistry;2022-12-27

5. NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation;PLOS ONE;2020-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3